Armoured GPC3 CAR T Cells Show Promise Against Liver Cancer, but Hurdles Remain
An armoured GPC3-targeted CAR T cell therapy engineered to resist TGFβ-mediated immunosuppression showed promising initial results in 36 patients with ...
An armoured GPC3-targeted CAR T cell therapy engineered to resist TGFβ-mediated immunosuppression showed promising initial results in 36 patients with ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine